Implantable Bioscaffolds
Total Trials
8
As Lead Sponsor
6
As Collaborator
2
Total Enrollment
1,836
NCT02629328
CardioCel Tri-leaflet Repair Study
Phase: N/A
Role: Lead Sponsor
Start: Sep 30, 2015
Completion: Nov 19, 2018
NCT02681341
Vascular Post Market Review
Role: Collaborator
Start: Feb 29, 2016
Completion: Sep 21, 2017
NCT04178213
First in Human Feasibility Study With ADAPT 3D - ALR for Aortic Leaflet Repair
Start: Mar 26, 2020
Completion: Jun 30, 2022
NCT05182307
DurAVR™ THV System: First-In-Human Study
Start: Nov 15, 2021
Completion: Jan 31, 2025
NCT05567809
Defining Exercise Hemodynamics and Function After Transcatheter Aortic Valve Replacement (DEFINE-TAVR) Study.
Start: Oct 25, 2022
Completion: Jan 21, 2025
NCT05712161
Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study
Start: Aug 7, 2023
Completion: Dec 31, 2033
NCT06510855
DurAVR™ THV EU-EFS
Start: Oct 31, 2024
Completion: Oct 31, 2030
NCT07194265
A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System
Start: Oct 31, 2025
Completion: Dec 31, 2037
Loading map...